WADA approves the List of Prohibited Substances and Methods for 2013
Executive Committee approves 2013 Prohibited List and reviews Code recommendations
September 10, 2012
The World Anti-Doping Agency (WADA) today approved the List of Prohibited Substances and Methods for 2013 at its Executive Committee meeting in London.
The new List will be made official and published by October 1 and will take effect on January 1, 2013.
As one of the cornerstones in the global fight against doping, the List specifies substances and methods prohibited in sport, and it is a mandatory document for all organizations that have adopted the World Anti-Doping Code.
The annual revision of the List is a highly-consultative process facilitated by WADA, and begins with circulation of a draft List amongst its stakeholders. Comments are considered by WADA’s List Expert Group, which then presents its conclusions to WADA’s Health, Medical and Research Committee (HMRC).
Recommendations are then made to WADA’s Executive Committee, which discusses the proposals before making a final decision at its September meeting.
“WADA is mandated to lead the scientific debate and serve as the catalyst for scientific advancements in the fight against doping in sport, and updating the List is a key component of that role,” explained WADA President John Fahey.
“The List is updated on an annual basis following thorough consultation with our stakeholders, and we are confident that since 2004 – the year in which WADA took responsibility for the List – we have developed a process that allows us to deliver as comprehensive a document as possible.
“Every year WADA is presented with new scientific and medical challenges and updating the List on an annual basis is one of the ways by which we keep on top of these developments,” added Mr. Fahey.
“The changes for 2013 will again add greater clarity to the List, and consequently it will be a better document to serve the world’s anti-doping community.”
2013 Monitoring Program
WADA, in consultation with Signatories and governments, is mandated to establish a Monitoring Program for substances which are not on the Prohibited List but which WADA wishes to monitor in order to detect patterns of misuse in sport.
Pain relief medicine tapentadol has been added to the 2013 Monitoring Program, under narcotics to be monitored for possible in-competition abuse.